Stryker Corporation's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "End-Period-Cash-Flow" stands at 11.60 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025.
Stryker Corporation's third quarter result of 3.26 Billion USD for the item "End Period Cash Flow" represents an increase of 37.09 percent compared to it's second quarter result.
Also, Stryker Corporation's third quarter result of 3.26 Billion USD for the item "End Period Cash Flow" represents a decrease of -15.43 percent compared to it's third quarter result of last year.
Looking again at the trailing twelve months series (TTM), Stryker Corporation's third quarter result of 11.60 Billion USD for the item "End Period Cash Flow" represents a decrease of -4.87 percent compared to it's second quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 5.24 percent compared to the value the year prior.
The 1 year change in percent is 5.24.
The 3 year change in percent is 68.99.
The 5 year change in percent is -47.07.
The 10 year change in percent is 13.11.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Abbott Laboratories - End Period Cash Flow | 217,696,616,448.00 |
![]() | Intuitive Surgical Inc - End Period Cash Flow | 206,245,888,000.00 |
![]() | EssilorLuxottica S. A. - End Period Cash Flow | 172,241,486,586.05 |
![]() | Danaher Corporation - End Period Cash Flow | 162,006,663,168.00 |
![]() | Boston Scientific Corp - End Period Cash Flow | 144,567,730,176.00 |